Interleukin-23 as a potential therapeutic target for rheumatoid arthritis
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interleukin-23 as a potential therapeutic target for rheumatoid arthritis
Authors
Keywords
-
Journal
MOLECULAR AND CELLULAR BIOCHEMISTRY
Volume 361, Issue 1-2, Pages 243-248
Publisher
Springer Nature
Online
2011-10-19
DOI
10.1007/s11010-011-1109-6
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
- (2016) Aarat Patel et al. Drug Design Development and Therapy
- IL-23 Induces Receptor Activator of NF- B Ligand Expression on CD4+ T Cells and Promotes Osteoclastogenesis in an Autoimmune Arthritis Model
- (2014) J. H. Ju et al. JOURNAL OF IMMUNOLOGY
- The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
- (2011) Paola Di Meglio et al. PLoS One
- The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis
- (2010) Xia Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Anti-IL-lα autoantibodies in patients with rheumatic diseases and in healthy subjects
- (2010) H. SUZUKI et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Increased Interleukin 21 (IL-21) and IL-23 Are Associated with Increased Disease Activity and with Radiographic Status in Patients with Early Rheumatoid Arthritis
- (2010) T. K. RASMUSSEN et al. JOURNAL OF RHEUMATOLOGY
- Systemic levels of IL-23 are strongly associated with disease activity in rheumatoid arthritis but not spondyloarthritis
- (2009) L. Melis et al. ANNALS OF THE RHEUMATIC DISEASES
- IL-23, not IL-12, Directs Autoimmunity to the Goodpasture Antigen
- (2009) J. D. Ooi et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Infliximab treatment reduces the serum levels of interleukin-23 in patients with rheumatoid arthritis
- (2009) Yasunori Kageyama et al. Modern Rheumatology
- IL-23 in the Pathogenesis of Rheumatoid Arthritis
- (2009) A. Paradowska-Gorycka et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Abundant expression of the interleukin (IL)23 subunit p19, but low levels of bioactive IL23 in the rheumatoid synovium: differential expression and Toll-like receptor-(TLR) dependent regulation of the IL23 subunits, p19 and p40, in rheumatoid arthritis
- (2008) F Brentano et al. ANNALS OF THE RHEUMATIC DISEASES
- Anti-inflammatory therapy with tumour necrosis factor alpha inhibitors improves high-density lipoprotein cholesterol antioxidative capacity in rheumatoid arthritis patients
- (2008) C Popa et al. ANNALS OF THE RHEUMATIC DISEASES
- Interleukin-12 family members and the balance between rejection and tolerance
- (2008) Stanislas Goriely et al. Current Opinion in Organ Transplantation
- Interleukin-23 Restrains Regulatory T Cell Activity to Drive T Cell-Dependent Colitis
- (2008) Ana Izcue et al. IMMUNITY
- Interleukin-23: Immunological roles and clinical implications
- (2008) Zi Yan Tan et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Interleukin 23: A key cytokine in chronic inflammatory disease
- (2008) Daniel Wendling JOINT BONE SPINE
- The Structure of Interleukin-23 Reveals the Molecular Basis of p40 Subunit Sharing with Interleukin-12
- (2008) Patrick J. Lupardus et al. JOURNAL OF MOLECULAR BIOLOGY
- Induction and effector functions of TH17 cells
- (2008) Estelle Bettelli et al. NATURE
- Lack of association between interleukin 23 receptor gene polymorphisms and rheumatoid arthritis susceptibility
- (2008) Jeong Ha Park et al. RHEUMATOLOGY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started